INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,021,031
Share change
+1,245,650
Total reported value
$76,762,000
Price per share
$25.41
Number of holders
6
Value change
+$31,650,883
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q2 2017

As of 30 Jun 2017, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,021,031 shares. The largest 6 holders included NEW YORK LIFE INSURANCE CO, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, JANE STREET GROUP, LLC, RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, and CITIGROUP INC. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.